Showing results (941-950 of 3,886) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|July 29, 2026
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapyBo Zhou, Zhixin Wang, Jun Qi, et al.
Cancer Biology & Therapy|July 26, 2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancerAllison S Doermann, Adi Caspi, Andrew E Evans, et al.
Cancer Biology & Therapy|September 8, 2026
Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translationPınar Peker
Cancer Biology & Therapy|September 9, 2026
DNA-PKcs and PARP1 at the interface between DNA damage responses and cGAS-STING signaling: context-dependent roles and therapeutic implicationsTiantian Miao, Jiaqi Zhao, Jinghong Wu, et al.
Cancer Biology & Therapy|September 25, 2026
Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)Li Zhou, Jin Ke, Shanlan Zhang, et al.
Cancer Biology & Therapy|October 10, 2026
RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualizationMeilin Chen, Xiwen Yan, Qifan Chen, et al.
Cancer Biology & Therapy|November 6, 2026
GPRIN1 enhances gallbladder cancer progression and is associated with the CDK1 pathwayMin Li, Xiaojian Ni, Zijun Gong, et al.
Cancer Biology & Therapy|October 13, 2022
Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivoZhiyuan Zhou, Xiaofeng Wu, Riming Zhan, et al.
Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.
Cancer Biology & Therapy|December 9, 2014
Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated ratsShusuke Toden, Trevor J Lockett, David L Topping, et al.
Pageof 389